Norges Bank’s Bicycle Therapeutics BCYC Stock Holding History

Norges Bank’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29,528	Closed	-$336K	–	2079
2019 Q3	$336K	Sell	29,528 -20,472	-41%	-$176K	﹤0.01%	2071
2019 Q2	$503K	Buy	+50,000	New	+$602K	﹤0.01%	2055

Other funds holding BCYC

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank's BCYC Position: Q4 2019 in Review

Norges Bank sold out of Bicycle Therapeutics (BCYC) in Q4 2019, closing a stake of 29,528 shares — an estimated $336K sold.

Norges Bank first reported a position in BCYC in Q2 2019 and held it in 2 quarters. The position peaked at $503K in Q2 2019. 10 funds tracked by Wall St. Rank hold BCYC as of Q4 2019.

Norges Bank reported no remaining Bicycle Therapeutics position as of Q4 2019 after selling out during the quarter.
Norges Bank sold 29,528 Bicycle Therapeutics shares in Q4 2019, an estimated $336K.
Norges Bank first reported a position in Bicycle Therapeutics in Q2 2019 and held it in 2 quarters.
Norges Bank's Bicycle Therapeutics position peaked at $503K in Q2 2019.
10 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2019.

Based on Norges Bank's 13F filing for Q4 2019, filed 12 Feb 2020.